CAN
ZVRA icon

Cetera Advisor Networks’s Zevra Therapeutics ZVRA Stock Holding History

Cetera Advisor Networks’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,500
Closed -$117K – 2137
2021
Q3 		$117K Sell
12,500
-400
-3% -$4.03K ﹤0.01% 1877
2021
Q2 		$165K Hold
12,900
– – ﹤0.01% 1796
2021
Q1 		$119K Buy
+12,900
New +$113K ﹤0.01% 1428

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $278M AUM 38.65% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cetera Advisor Networks's ZVRA Position: Q4 2021 in Review

Cetera Advisor Networks sold out of Zevra Therapeutics (ZVRA) in Q4 2021, closing a stake of 12,500 shares — an estimated $117K sold.

Cetera Advisor Networks first reported a position in ZVRA in Q1 2021 and held it in 3 quarters. The position peaked at $165K in Q2 2021. 77 funds tracked by Wall St. Rank hold ZVRA as of Q4 2021.

  • Cetera Advisor Networks reported no remaining Zevra Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Cetera Advisor Networks sold 12,500 Zevra Therapeutics shares in Q4 2021, an estimated $117K.
  • Cetera Advisor Networks first reported a position in Zevra Therapeutics in Q1 2021 and held it in 3 quarters.
  • Cetera Advisor Networks's Zevra Therapeutics position peaked at $165K in Q2 2021.
  • 77 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q4 2021.

Based on Cetera Advisor Networks's 13F filing for Q4 2021, filed 14 Feb 2022.